European Hematology Association 24th Congress

The 2019 European Hematology Association Annual Meeting is being held in Amsterdam, offering a program that is designed to teach, engage, and bring the hematology field together. Stay tuned for updates starting June 13th.

leukemia

Targeting NADK Holds Promise in Treating NOTCH1-Driven T-Cell Acute Lymphoblastic Leukemia

Research presented at the 24th Congress of the European Hematology Association (EHA) found that potent inhibitors of NADK (NAD Kinase) could potentially enhance the...
Doctor and man

EHA: Addition of Daratumumab to Standard of Care Improves Response in Newly Diagnosed Myeloma

Research presented at the European Hematology Association 24th Congress found that the addition of daratumumab to bortezomib, thalidomide, and dexamethasone
Latest News

Breaking News from EHA 2019 in Amsterdam

Check out the latest news from the 24th Congress of the European Hematology Association. Targeting NADK Holds Promise in Treating NOTCH1-Driven T-Cell Acute Lymphoblastic Leukemia Research...
sickle cell

EHA: Voxelotor for Sickle Cell Disease Has Disease-Modifying Potential

European Hematology Association 24th Congress found that voxelotor significantly increased hemoglobin levels and reduced markers of hemolysis in patients with sickle cell disease.
brca

Study Finds Gene Therapy Effective in Treating Thalassemia

Research presented last week at the 24th Congress of European Hematology Association (EHA) in Amsterdam found gene therapy to be effective in treating animal models of thalassemia....

Hem/Onc Journal Reading List

Advertisement